|
|
 |
|
Viewing report
|
|
|
|
Netherlands: Pharmaceuticals Industry Guide
Datamonitor, March 2011, Pages: 73
The Netherlands: Pharmaceuticals Industry Guide is an essential resource for top-level data and analysis covering the Netherlands Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape. This incisive report provides expert analysis with distinct chapters for Biotechnology, Generics, OTC Pharmaceuticals and Pharmaceuticals
Scope of the Report
- Contains an executive summary and data on value, volume and segmentation for Biotechnology, Generics, OTC Pharmaceuticals and Pharmaceuticals
- Provides textual analysis of the industry's prospects
- Incorporates in-depth five forces competitive environment analysis and scorecards
- Includes five-year forecasts for Biotechnology, Generics, OTC Pharmaceuticals and Pharmaceuticals
Highlights
The Dutch biotechnology market had total revenue of $330.5 million in 2009, representing a compound annual growth rate (CAGR) of 5.1% for the period spanning 2005-2009.
The Dutch generics market had total revenue of $1 billion in 2009, representing a compound annual growth rate (CAGR) of 11.6% for the period spanning 2005-2009.
The Dutch OTC pharmaceuticals market generated total revenues of $1.1 billion in 2009, representing a compound annual growth rate (CAGR) of 1.9% for the period spanning 2005-2009.
The Dutch pharmaceuticals market is forecast to have total revenue of $5.8 billion in 2010, representing a compound annual growth rate (CAGR) of 0.6% for the period spanning 2006-2010.
Why you should buy this report
- Spot future trends and developments
- Inform your business decisions
- Add weight to presentations and marketing materials
- Save time carrying out entry-level research
|
|
|
|
